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STRATEGIC PLANNING

New $600 million Board approves nine-year strategic plan
campaign launches by ZACH VEILLEUX
by LESLIE CHURCH
With the introduction of an ambitious new
strategic plan, The Rockefeller University is
also embarking on a fundraising initiative,
to be called the Campaign for Transforming
Biomedicine. The campaign seeks to raise at
least $600 million in nine years to facilitate
the university’s vision of bridging fundamental science with research on disease.
The initiative is already off to a strong
start. Its first fiscal year, which ends this
June, has seen $130 million in gifts including 21 donations of $1 million or more. It
is among the best fundraising years in the
university’s history — second only to 2005,
when David Rockefeller made a commitment of $100 million.
The university’s previous fundraising
campaign, the seven-year Campaign for
Collaborative Science, concluded in 2011
having raised nearly $628 million in gifts
and grants and exceeding its original goal
of $500 million set in 2003. Approximately
$152 million of that total came in the form
of flexible funds to finance construction of
the Collaborative Research Center.
The new campaign kicks off with two
new trustee gifts announced at last week’s
Board meeting: a $25 million unrestricted
gift from the Carson Family Charitable
Trust, headed by Russell L. Carson, and a
$20 million gift from the Simons Foundation to support faculty recruitment.
“The strategic plan that Marc and the
faculty have put forth is tremendously
exciting and will strengthen both basic and
translational research at the university,”
says Mr. Carson, chair of the university’s
Board of Trustees. “My family’s financial
commitment reflects our firm belief that
Rockefeller maintains a standard of excellence that sets it apart and that ensures that
its faculty will continue to make transformational discoveries in the years ahead.”
In recognition of Mr. Carson’s donation,
Marc Tessier-Lavigne will be named the
Carson Family Professor.
The gift from the Simons Foundation,
a philanthropy founded by mathematician
James H. Simons, a member of the Board
since 2000, and his wife Marilyn, will be
used primarily for faculty recruitment. The
Simons Foundation sponsors a range of programs to advance the frontiers of research in
mathematics and the basic sciences.
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CAMPUS NEWS

Nobel winnings to fund Cohn-Steinman professorship
by ZACH VEILLEUX
Ralph M. Steinman, head of the Laboratory of Cellular Physiology and Immunology, died just three days before winning the
Nobel Prize last year. But his legacy at the
university will live on: with a gift from the
Steinman family and the support of over
120 donors including many of his colleagues
and lab alumni, the university has established the Cohn-Steinman Professorship at
Rockefeller.
The $500,000 donated by the Steinmans
comes directly from Dr. Steinman’s Nobel

Prize winnings. It was Dr. Steinman’s wish
during his life to honor his mentor and
collaborator, Zanvil A. Cohn, with whom
he discovered dendritic cells and made scientific discoveries that transformed the field
of immunology.
“We believe there could be no more
fitting tribute to the work of these two
brilliant scientists than the establishment of
a named chair in their honor. The CohnSteinman Professorship would honor Zan
and Ralph in perpetuity and celebrate the

continued on page 2
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Diplomatic immunity. Zanvil Cohn (left) and Ralph Steinman in 1983.

extraordinary roles they played both on the
Rockefeller campus and in the global scientific community,” says Marc Tessier-Lavigne,
the university’s president.
To create the Cohn-Steinman chair, Rockefeller has received 129 gifts totaling $2.6
million toward its $3 million goal. A total
of 129 gifts and pledges from Dr. Steinman’s
colleagues, trainees and friends have been received by the university in amounts ranging
from $100 to $1 million. One Rockefeller
alumnus and former faculty member anonymously contributed $1 million to the chair in
honor of Steinman and Cohn, with whom he
worked while at Rockefeller.
The Steinman family has contributed an
additional $250,000 from the Nobel Prize
to The Steinman Family Foundation to
support the careers of young scientists and
science education.
“As a family we were very moved by the
creation of this chair in Ralph and Zan’s
honor,” says Claudia Steinman, Ralph’s
wife. “The Rockefeller University was
Ralph’s scientific home for 40 years. His
commitment to mentoring and cooperation
were hallmarks of his career as they were
for his dear friend Zan Cohn. Ralph often
said ‘none of us is as smart as all of us.’ We
know that the establishment of The CohnSteinman Professorship will carry on that
spirit of collaboration.”

Strategic plan

(continued from page 1)

acknowledging that biomedicine has reached a point where
the discoveries of fundamental science can be applied
broadly and systematically to accelerate the understanding
of human biology and disease.
The plan has six components:
1. Faculty recruitment. The strategic plan reaffirms the
importance of the open search mechanism to recruit junior
faculty. The open search, which has already been in use
for six years, allows the university to pursue the best and
brightest scientists regardless of their field of study. The
plan calls for the continuation of the open search, to be
augmented by a more active search component that will
take advantage of existing faculty relationships in order to
reach out to talented candidates that might not otherwise
submit applications to Rockefeller.
It also calls for increased hiring of mid-career scientists,
who have already achieved a track record of success at
other institutions and who are still in the ascent of their careers. Overall, the plan calls for the addition of 12 tenuretrack and six mid-career scientists over a nine-year term, a
pace of hiring that Dr. Tessier-Lavigne says will compensate
for retirements and departures and maintain the university’s current size of approximately 70 to 75 labs.
2. Education. As expected, the plan reaffirms the importance of providing financial support to graduate students
and postdoctoral researchers, a practice that allows the
university to compete for top students. The strategy calls
for working to increase Rockefeller’s visibility to potential
applicants and improving mechanisms for identifying talent overseas.
3. Basic research program development. Generous direct support to individual faculty has been a key component
of the university’s success over the years, making it possible
for scientists to embark on projects for which grant funding
might be difficult to secure. The plan calls for the continuation of this practice, which is not widely used elsewhere and
is therefore an important recruiting and enabling tool.
The plan also calls for the creation of new interdisciplinary research centers, where opportunities exist. The
centers, which seek to increase interactions and collaboration among labs that are working in similar areas, may
also invest in shared technologies and infrastructure and
help individual labs better take advantage of economies
of scale. Eight research centers currently exist, including
the new Center for Basic and Translational Research on
Diseases of the Digestive System; a ninth, to be called the
Center for Genomic Medicine, is in development.
4. Medical sciences and biotechnology. Members of the
strategic planning committee reaffirmed the university’s

commitment to one of its unique institutions: its clinical
research hospital that has since its founding served as a
model for the investigation of human disease. Under its
current leadership, the hospital has successfully lowered
barriers to conducting human subjects research, and as a
result a record number of laboratories — almost half —
have protocols using human subjects. The plan calls for a
continued commitment to the hospital and its programs,
including necessary renovations. It also calls for enhancements to hospital infrastructure to support future translational work, to be pursued in collaboration with Weill
Cornell Medical Center and Memorial Sloan-Kettering
Cancer Center.
5. Environment for discovery. “Providing our scientists
with access to the tools and technology they need to make
discoveries is absolutely vital to the university’s mission,”
says Dr. Tessier-Lavigne. The planning committee has
identified two areas where there are immediate needs for
investment: in DNA sequencing and in bioinformatics. The
plan calls for access to DNA sequencing via the New York
Genome Center and complementary upgrades to bioinformatics capabilities on campus to facilitate the analysis of genomic data. Additional investments may be required as new
technologies become available and as faculty needs change.
Just as important is the ongoing need for modern, well
equipped lab space that can support the requirements of
today’s collaborative, technology-intensive research environments. An analysis of the university’s space, accounting
for new recruitment as well as attrition, projects a need
for approximately 66,000 square feet of ready-to-use lab
space over the nine-year term of the plan — about twice
what the university has available. “What this means is that
although we do not currently have a shortage of space,
we expect to face one in about four to five years,” says Dr.
Tessier-Lavigne. “At that point we will have two options:
we can build or we can renovate.”
The strategic planning committee, as well as the master
planning committee that has been charged with evaluating
the university’s infrastructure needs, favors a plan developed by Rafael Viñoly Architects to expand the campus
eastward by creating a two-story laboratory building on a
long platform over the FDR Drive. This plan, which would
in effect increase the size of the campus by two acres and
would feature a landscaped roof level with and linked to
the current grounds, would contain as much as 160,000
square feet of space as well as additional facilities such as
a new café and administrative offices. This “river building”
would preserve existing views and leave the remainder of
the campus available for future development if needed.
(More details about the proposed building will be discussed in a future BenchMarks.)

Fundraising campaign
“Marilyn and I are pleased to support
The Rockefeller University as it enters an
exciting new chapter in its history,” says
Dr. Simons. “The university sets an exceptionally high bar in the laboratory heads it
recruits. World class faculty, in turn, help to
attract the best graduate students and postdoctoral fellows, thereby creating a vibrant
culture for excellent research.”
Other major gifts in this year’s total
include a previously announced donation
of $10 million from the Robertson Foundation, headed by Trustee Emeritus Julian
Robertson, to support the university’s
search for the best early-career scientists
to join the faculty. In addition, a grant of
$15 million from the Leona M. and Harry
B. Helmsley Charitable Trust has created
a new interdisciplinary center in research
related to diseases of the digestive system.
The university’s Women&Science initiative, now in its 15th year, raised a record
$5.1 million for breast cancer research,
far surpassing its original goal of $3.5
million. Leadership benefactors including
Trustee Marlene Hess, Jeanne Donovan
Fisher and the Helena Rubinstein Foundation provided challenge grants, which
are donations that match the university’s
fundraising efforts from other sources.
The Irene Diamond Fund was also a major
contributor.
The effort to raise funds for the CohnSteinman Professorship announced in April
has also been highly successful (see “Nobel
winnings to fund Cohn-Steinman professorship,” page 1).
Among the specific fundraising goals of
the Campaign for Transforming Biomedicine are $60 million for the recruitment
of new faculty, $50 million for funds to

(continued from page 1)

support medical sciences and biotechnology, including translational research pilot
grants and the development of new therapeutics, and $100 million to strengthen
the university’s endowment. Additional
funds will benefit human genetics research,
including the creation of the new Center
for Genomic Medicine, and provide for the
acquisition of new technologies.
In addition, the need for laboratory
renovations and other campus construction
projects constitute a major funding goal.
The university aims to raise between $115
million and $365 million toward building
costs, depending on the outcome of the
master planning process now under way
(see “Board approves nine-year strategic
plan,” page 1). If university officials decide
to proceed with a new research building
over the FDR Drive, the financial goal
would rise above $600 million.
“Compared to previous campaigns, this
one is very ambitious given that the economy is still challenged,” says Marnie Imhoff,
vice president for development. “It’s clear
that private support is more critical now
than ever before, as NIH funding has
been flat and instability of capital markets
means uncertainty about the future of our
endowment returns. Thanks to the generosity of the university’s supporters, we are off
to a great start on this campaign.”
“A strategic plan is only as strong as
the funding behind it,” says Dr. TessierLavigne. “We are grateful to have so many
benefactors who believe in Rockefeller’s
mission and continued success as an engine
of transformative discoveries. It’s the
donors that will turn this plan into a reality
and enable our researchers to make those
discoveries.”

An alternative to new construction would be renovations to multiple floors in the Weiss Building, built in the
early 1970s. Although this option, which is less expensive
than building from scratch, would buy time, it would not
address the university’s long-term need for space.
“While the Rafael Viñoly plan would be a phenomenal
addition to the campus, much work needs to be done
over the next several months to evaluate its feasibility and
fundability,” says Dr. Tessier-Lavigne. “We plan to pursue
city approval for this project and further refine the cost
estimates for the river building, and both the Academic
Council and the Board will continue to study our options
with the goal of making a decision on how to proceed in
the next year.”
In addition, improvements will need to be made to
several other buildings over the coming years, including the
Graduate Student Residence and Sophie Fricke Hall, and a
permanent location will need to be found for the Information Technology department, which is currently located in
a temporary building.
6. Beyond our walls. Although New York City receives
more NIH grant money than all but one other city —
Boston — it is not traditionally seen as a biomedical
powerhouse. The planning committee, however, believes
New York is on the cusp of realizing its potential, and that
Rockefeller can play a leadership role in helping make
this happen. “By joining with other institutions in the city,
as well as with the region’s growing biotechnology and
pharmaceutical industries, we can help foster productive
collaborations in the academic sector and also accelerate
the movement of discoveries to the commercial sector,”
says Dr. Tessier-Lavigne.
In addition to these six main components, there are
two additional ongoing areas of focus that the committee
felt should be pursued vigorously: the preservation of the
university’s culture and the enhancement of its visibility
locally, nationally and internationally. This is to be accomplished by continuing to invest in outreach and communications programs that engage with the community and the
public at large.
“The plan we have now adopted is an ambitious one
and there is much work to be done to implement all that
has been proposed,” says Dr. Tessier-Lavigne. “But this is
an institution that has sustained its excellence and remained at the leading edge of scientific discovery for more
than a century. Members of our community at all levels
have thought carefully about the concepts presented in this
plan, and I’m confident that this strategy is the right one
for the university as we position Rockefeller for success in
the next decade and beyond.”

CAMPUS NEWS

Genome Center to operate at
Rockefeller in interim
by LESLIE CHURCH
The New York Genome Center (NYGC),
the nonprofit institution set to become one
of the largest bioinformatics and genomics
facilities in North America, is launching
its pilot lab operations at The Rockefeller
University while a search is conducted for
a permanent facility.
Rockefeller, which is one of the Center’s
institutional founding members, was chosen as the temporary site because it had
modern lab space available that required
few modifications to accommodate the
scientists and equipment. The center began
operating on the east side of Smith Hall’s
C floor in June.
“The space in this area of Smith Hall
is newly renovated and is suitable for the
Genome Center’s needs, and it is not currently being used by the university,” says
John Tooze, vice president of scientific
and facility operations. “Our agreement
to lease them this ready-to-use space is a
demonstration of our commitment to this
cooperative New York City research initiative and it will allow them to get their lab
work under way quickly.”
The Genome Center began processing
sequencing requests this spring and is expected to open the doors to its permanent
facility early next year. The pilot lab at
Rockefeller will enable NYGC to expand
its service operations in advance of the
opening in 2013.
There will be 8 to 10 sequencing and

bioinformatics scientists from the NYGC
working in the lab, which can accommodate up to 10 high-throughput sequencing machines and support equipment.
The center signed a one-year lease with
Rockefeller, with the option to extend if
necessary.
The NYGC collaboration will bring
scientists and physicians from member
institutions together to share diverse clinical and genomic data in order to discover
the molecular underpinnings of disease,
identify and validate biomarkers, and
accelerate development of novel diagnostics and targeted therapeutics to improve
clinical care.
In February the center announced a major initiative to sequence whole genomes
of Alzheimer’s patients with the goal of
understanding the genetic basis of susceptibility to Alzheimer’s disease, a condition
about which very little is currently known.
Together with the Feinstein Institute
for Medical Research, part of founding
member North Shore-Long Island Jeweish Health System, the NYGC plans to
sequence up to 1,000 genomes over four
years.
The NYGC also has begun a project
with Jean-Laurent Casanova, head of the
St. Giles Laboratory of Human Genetics
of Infectious Diseases at Rockefeller, to
sequence 1,000 exomes as part of his immune disorder research.

CAMPUS NEWS

Recent computer attacks on campus target Macs, e-mail
by LESLIE CHURCH
It’s not just biologists who are studying
infection at Rockefeller. Computer security
experts based in the IT Pavilion have been
kept busy in recent months managing
outbreaks of viruses and other malware on
campus computers.
In June more than a dozen people on
campus fell victim to a phishing attack,
a type of attack in which hackers send emails from what appears to be a trustworthy source asking for personal information
such as a username and password. And

the IT staff spent much of April working
to repair damage caused by the Flashback
trojan, a piece of malware that infected
30 Macintosh computers on campus and
hundreds of thousands worldwide.
In the phishing attack, hackers sent
e-mails to campus users stating that their email quota was at capacity and prompting
them to follow a link to fix the problem.
Users who clicked the malicious link were
prompted to enter their passwords, which
the hackers then used to log on to that per-
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son’s e-mail account and send thousands of
malicious e-mails to both university members and external e-mail addresses. This
led HHMI, AOL and Gmail, among others,
to quickly throttle the university’s e-mail
traffic, drastically slowing the rate at which
Rockefeller e-mails could be delivered.
“IT will never ever ask you for your
password,” says Marty Leidner, chief
information security officer. “Users must
be particularly careful to only enter their
passwords on a Web site they purposely
went to. You can also hover your mouse,
without clicking, over a link in an e-mail to
see where the link will take you. If it looks
the least bit suspicious, don’t click on it.”
The Flashback trojan works like the
Trojan horse for which it is named: it
sneaks onto computers when the user visits
an infected Web site and agrees to a seemingly innocuous download of bad code.
On the surface everything looked fine. But
back in the IT pavilion, staff could see that
computers on campus were being hijacked
and forced to join a botnet: a network of
computers controlled by a cybercriminal.
Meanwhile, the Flashback trojan was
at work on the users’ browsers, intercepting search queries and returning fraudulent results. It’s part of a global criminal
scheme: every time someone clicks on one
of the fake results, the owners of the botnet
get paid.
“This isn’t the lone hacker making a
name for him or herself and showing off
how cool they are,” says Bart Mallio, information security intelligence analyst at Rockefeller. “When the internet got monetized
with electronic commerce, organized crime
groups started getting involved. The cybercriminals behind Flashback struck a deal
with companies to get paid for making their
sites come up first in a search results list.”
It’s not known who created the malware, but with more than 600,000 computers infected worldwide, it’s estimated the
criminals were raking in $10,000 a day.
Rockefeller’s information security

personnel responded to the outbreak by
first quarantining and then patching the affected computers with software that blocks
the trojan. Although no data was stolen,
the potential for a data breach exists whenever a virus, worm or trojan enters the
Rockefeller network.
“The malware had control of people’s
machines — it could have done many damaging things. It could have, for example,
stolen electronic banking credentials,” says
Leidner.
The fact that only Mac computers were
targeted shows a shifting trend in the world
of computer viruses and hacking. Macs
were traditionally thought to be resistant
to malware because hackers would create
viruses that targeted the majority of machines out there: Windows PCs. As Apple’s
popularity has risen — Macs constitute
about 40 percent of campus computers —
cybercriminals see an easy target on devices
that often don’t have antimalware software
installed.
While the number of attempted attacks
on all campus computers has seen a sharp
rise in the last three years, the number of
attacks that successfully infected computers
has dropped, thanks to upgraded network
hardware and antimalware software on
campus computers. In the first four months
of this year there has been a 60 percent reduction in malicious attacks on the campus
compared to the same time frame in 2011
(see charts, left). However, although there
have been fewer attacks, the severity of the
average attack is increasing, requiring more
time and resources to mitigate.
The most important steps one can
take to safeguard a computer are to run
antimalware and promptly and regularly
patch all computer programs. IT launched a
campus ad campaign in April to encourage
Mac users to download Symantec Endpoint
Protection, which is available for free to
the Rockefeller community. The campaign
resulted in over 200 Mac users on campus
installing Symantec for the first time.

10.0

Employees honored for longtime service to university
Members of the Rockefeller faculty and staff were recognized for their service to the university with two recent events. The Employee Recognition Cocktail Reception in February honored employees who had
worked at the university for 20 and 25 years. Fifty-nine employees celebrated 20 years of service and 29 celebrated 30 years. In June the university held an anniversary dinner for employees celebrating major
anniversaries of 30 or more years as well as retirements. Honorees at that dinner are pictured below. To see more photos, visit www.rockefeller.edu/employeerecognition.

“It’s the people. There’s something about
working with wacky geniuses that brings
out the best in you.”
 Regina Metz, 30 years

“There is always a feeling that we are a closeknit family, which has made it a place I enjoy
coming to every day.”
120.0

 Frank Colosi, 45 years
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“The students are exceptional. The staff is
extraordinarily helpful. And one is surrounded
by…excellent scientists in many ﬁelds. What
more can one want?”
David Mauzerall, 55 years 

“Rockefeller has an uncanny ability to renew
itself so that it always remains young and
vibrant.”

 Emil Gotschlich, 50 years

Milestones
PROMOTIONS, AWARDS AND PERSONNEL NEWS

Awarded:
Jesse H. Ausubel, the 2012 National Ocean

Champion Award, presented by the Urban
Coast Institute of Monmouth University in
New Jersey, for his contributions to marine
science and management. Mr. Ausubel joins
a distinguished group of awardees, including
Jean-Michel Cousteau, who won in 2011. He
is the director and senior research associate of
the Program for the Human Environment.
Cori Bargmann, the 2012 Kavli Prize in Neu-

roscience, which is awarded biennially for
outstanding achievement in advancing knowledge and understanding of the brain and
nervous system. Dr. Bargmann is among the
first women scientists to receive the $1 million prize, which was first awarded in 2008
and recognizes her efforts in elucidating basic
neuronal mechanisms underlying perception
and decision. Dr. Bargmann is the Torsten N.
Wiesel Professor at Rockefeller, head of the
Lulu and Anthony Wang Laboratory of Neural Circuits and Behavior and an investigator
at the Howard Hughes Medical Institute.
Cori Bargmann, the 2012 Dart/NYU Biotech-

nology Achievement Award in Basic Biotechnology, for her work in deciphering the neural
networks that define individual and group
behaviors. Presented by the Biotechnology
Study Center of NYU School of Medicine, the
prize recognizes the role of pure science in the
development of pharmaceuticals and honors
scientists whose work has led to major advances in improving patient care.
Jan L. Breslow, the 2012 Robert I. Levy
Award, presented by the Kinetics and Metabolism Society. The award, presented in April,
is given to a researcher who has made valuable contributions to the field of lipoprotein
metabolism. Dr. Breslow is senior attending
physician, Frederick Henry Leonhardt Professor and head of the Laboratory of Biochemical Genetics and Metabolism.
Brian T. Chait, the 2012 Pehr Edman Award

from the International Association for Protein
Structure Analysis and Proteomics. The award
is presented to individuals whose efforts have
significantly advanced the fields of protein
chemistry, protein structure analysis or proteomics. Dr. Chait is the Camille and Henry
Dreyfus Professor and head of the Laboratory of Mass Spectrometry and Gaseous Ion
Chemistry.

James E. Darnell Jr. and Robert G. Roeder, the

2012 Albany Medical Center Prize in Medicine and Biomedical Research, for pioneering
achievements in understanding how genes are
regulated and expressed. The nation’s largest
prize in medicine at $500,000, the award is
given to scientists or physicians whose work
has led to significant advances in health care
and scientific research with demonstrated
translational benefits. Dr. Darnell is the Vincent
Astor Professor Emeritus and head of the Laboratory of Molecular Cell Biology. Dr. Roeder
is the Arnold and Mabel Beckman Professor
and head of the Laboratory of Biochemistry

and Molecular Biology. Three other Rockefeller
scientists have previously received the prize.
Titia de Lange, the Dr H.P. Heineken Prize for

Biochemistry and Biophysics for her research
on telomeres. The award was presented by
the Royal Netherlands Academy for Arts and
Sciences and included a $150,000 prize. It
was the first time this award was given to a
woman. Past Rockefeller recipients include
Christian de Duve and Paul Nurse. Dr. de
Lange is the Leon Hess Professor and head of
the Laboratory of Cell Biology and Genetics.

Herminia de Lencastre, the Professor Nicolau

van Uden Prize from the Portuguese Society of
Microbiology for lifetime contributions in the
field. The prize consists of a personal diploma
and honorary membership in the society. Dr.
de Lencastre is a senior research associate in
Alexander Tomasz’s Laboratory of Microbiology and Infectious Diseases.

Andrey Feklistov and Nicholas Stavropoulos,

Blavatnik Awards for Young Scientists. The
awards are given to researchers under the age
of 42 who demonstrate highly innovative,
impactful and interdisciplinary accomplishments in the life sciences, physical sciences,
mathematics and engineering. Dr. Feklistov, a
research associate in Seth A. Darst’s Laboratory of Molecular Biophysics, is being recognized for his work resolving a fundamental
transcription mechanism also important for
drug design. Dr. Stavropoulos, a research associate from Michael W. Young’s Laboratory
of Genetics, is being awarded for his research
on the function and regulation of sleep. They
will each receive $15,000 and will be honored
at the New York Academy of Sciences’s ninth
annual Science and the City Gala in November.

Susana Gardete, the 2012 Young Investiga-

tor Award from the Palm Beach Infectious
Diseases Institute. The $50,000 award is given
to a young investigator to support research in
infectious diseases and career development. Dr.
Gardete is a postdoctoral fellow in Alexander
Tomasz’s Laboratory of Microbiology and
Infectious Diseases.

Alexander Ploss, a 2012 American Liver
Foundation Gregg Allman Liver Scholar
Award. The award is given to early-career scientists to encourage the study of liver physiology and disease. Dr. Ploss, a research assistant
professor in Charles M. Rice’s Laboratory of
Virology and Infectious Disease, will receive
$225,000 over three years.
Jeffrey V. Ravetch and Michael W. Young, the

Canada Gairdner International Award, presented by The Gairdner Foundation, for significant discoveries in medical science. The award
is Canada’s highest scientific award and is
considered among the top 10 most prestigious
international prizes in science. Dr. Ravetch is
recognized for his work demonstrating how
our immune system can be both protective
and harmful. He is the Theresa and Eugene
M. Lang Professor and head of the Leonard
Wagner Laboratory of Molecular Genetics
and Immunology. Dr. Young is honored for his
research on circadian rhythms. He is the Rich-

ard and Jeanne Fisher Professor and head of
the Laboratory of Genetics. Drs. Ravetch and
Young each received a $100,000 prize.
Vanessa Ruta, a McKnight Scholar Award, for

her research on the functional organization of
the neural circuits underlying olfactory learning. Presented by the McKnight Endowment
Fund for Neuroscience, this year’s McKnight
awards were given to six early-career scientists
who have established independent laboratories
and have demonstrated a commitment to neuroscience. Dr. Ruta is assistant professor and
head of the Laboratory of Neurophysiology
and Behavior. She is one of seven Rockefeller
faculty who have won the award, and will
receive $75,000 per year for three years.
Caspar Schwiedrzik, the Human Frontier

Science Program Long-term Fellowship. The
fellowships are given to biologists who wish
to broaden their training in a different field
of the life sciences in another country. Dr.
Schwiedrzik joined Winrich Freiwald’s Laboratory of Neural Systems as a postdoctoral
fellow in January.

Caspar Schwiedrzik, the Barbara Wengeler

Award, from the Barbara Wengeler Foundation in Germany. The €10,000 award recognizes research conducted at the intersection of
neuroscience and philosophy, work that Dr.
Schwiedrzik did at the Max Planck Institute
for Brain Research.

Marc Tessier-Lavigne, the Henry G. Friesen

International Prize in Health Research, established by the Friends of Canadian Institutes
of Health Research in collaboration with the
Canadian Academy of Health Sciences. The
prize recognizes exceptional innovation by a
visionary health leader of international stature. It awards $35,000 and an invitation to
deliver a public lecture in Ottawa. Dr. TessierLavigne is head of the Laboratory of Brain
Development and Repair.

Anne Debassac, human resources administra-

tor, Human Resources.

Rickpaul Dhindsa, analyst, Investments.
Larissa Costa Faustino, visiting student, Pfaff

Lab.

Michele Filgate, laboratory administrator,

Chait Lab.

Ksenia Gnedeva, postdoctoral associate,

Hudspeth Lab.

Jamie Lynn Harden, postdoctoral associate,

Krueger Lab.

Raimond Herzog, member of the adjunct

faculty, Greengard Lab.

Zachi Horn, postdoctoral fellow, Hatten Lab.
Chung-Hao Huang, visiting student, Chua Lab.
Agata Jacewicz, postdoctoral associate,
O’Donnell Lab.
Trevor Johnson, research assistant, Simon Lab.
Christine Lai, research support assistant,

Genomics Resource Center.

Emily Lowry, postdoctoral associate,

Strickland Lab.

Hector Lugo, animal attendant, Comparative

Bioscience Center.

Joel Lutomiah, visiting student, Vosshall Lab.
Juan Carmelo Magniez, foreign research

intern, Libchaber Lab.

George Martinez, animal attendant,
Comparative Bioscience Center.
Ruben Martinez Barricarte, postdoctoral

associate, Casanova Lab.

Cristina Mascaraque, visiting student, Mucida

Lab.

Amanda Perkins, teacher, Child and Family

Center.

Erica Sanborn, genetic counselor,
Smogorzewska Lab.
Claudia Scheckel, postdoctoral fellow,

R. Darnell Lab.

Lianna Schwartz-Orbach, research assistant,

Rice Lab.

Julia Sliwa, postdoctoral associate, Freiwald

Elected:

Lab.

Cori Bargmann, to the American Philosophi-

cal Society, which elects members who have
shown extraordinary accomplishments in the
fields of math and physics, biology, humanities and social sciences, among others. She is
the ninth Rockefeller University faculty member to be inducted to the society.

Brendan Smith, research support assistant,
High Throughput Screening Resource Center.
Judit Soy-Platero, visiting student, Chua Lab.
Tom Szymczyk, Web site builder and
programmer, Information Technology.
Tiberiu Tesileanu, visiting fellow, Leibler Lab.
Yuko Ulrich, postdoctoral fellow, Kronauer

Lab.

Hired:
Elizabeth Adler, executive editor JGP,
Rockefeller University Press.

Amy Vonk, laboratory administrator,
Nottebohm Lab.

Leandro Alonso, visiting student, Magnasco

Promoted (academic appointments):

Jeffrey Barnett, research assistant, Breslow Lab.

Erin Norris, to senior research associate,
Strickland Lab.

Lab.

Claudia Bognanni, research assistant, Tuschl

Lab.

Dennis Brown, security guard, Security.
Rachel Chiaroni-Clarke, research assistant,

Simon Lab.

Leslie Church, assistant editor, Communications and Public Affairs.

Julio Cesar Padovan, to senior research
associate, Chait Lab.
This publication lists new hires, awards and
promotions. Staff promotions are listed yearly;
academic promotions and appointments are
listed monthly.

NEW TRUSTEE

Thomas P. Maniatis elected to Board
by LESLIE CHURCH

PHOTO: ZACH VEILLEUX

The university Board of
Trustees elected Thomas
P. Maniatis as its newest
member at its spring
meeting on March 14,
bringing the total number
of trustees to 43.
Dr. Maniatis is the
Isidore S. Edelman
Professor and Chairman
of the department of biochemistry and molecular
biophysics at Columbia
University Medical Center. He received his B.S.
and M.S. degrees from the University of Colorado, Boulder,
in chemistry and biology, and his Ph.D. in molecular biology from Vanderbilt University. After postdoctoral studies
at Harvard University and the Medical Research Council
Laboratory of Molecular Biology in Cambridge, England,

Dr. Maniatis held faculty positions at Harvard, the Cold
Spring Harbor Laboratory and the California Institute of
Technology.
“Tom is a preeminent scientist and scientific leader who
will be a superb addition to our Board,” says Marc TessierLavigne, the university’s president. “He already knows
the university well through his outstanding service on the
Board’s Committee on Scientific Affairs, and his perspective will serve to complement those of his fellow Board
members, the majority of whom are leaders in business and
finance.”
Dr. Maniatis is known for pioneering the development
of gene cloning technology and its application to basic
research and biotechnology. His research has impacted a
broad spectrum of biomedical fields, from basic mechanisms of gene regulation to human genetic and inflammatory diseases. His laboratory is currently focused on
molecular neuroscience, with interests in the role of single
cell diversity in the brain and disease mechanisms in ALS
(Lou Gehrig’s Disease).

In the past 30 years Dr. Maniatis has cofounded three
biotechnology companies. He is currently a member of the
board of directors of Acceleron Pharma and Constellation
Pharma, and is a science partner of The Column Group, a
biotechnology venture capital firm.
Dr. Maniatis is a member of the Jackson Laboratory
Board of Trustees and has served on the Board of Trustees
of the Cold Spring Harbor Laboratory. He currently serves
on The Rockefeller University Committee on Scientific
Affairs and is a former member of the Board of Scientific
Consultants at Memorial Sloan-Kettering Cancer Center.
He is a cofounder of the New York Genome Center and
sits on its Executive Committee.
“Rockefeller is an extraordinary research institution,
and I have many friends and colleagues on both the faculty
and the Board,” says Dr. Maniatis. “I enjoy serving on
the Rockefeller Committee on Scientific Affairs, and was
honored to be asked to join the Board. I look forward to
working with Marc and the other Board members to maintain Rockefeller’s preeminent position in the life sciences.”

